Embrace Artificial Intelligence in the Pharmacy
Drug Topics
OCTOBER 4, 2022
As technology advances in all areas of life, it is no surprise that technology is becoming more prevalent in independent pharmacy.
Tue.Oct 04, 2022
628 
Mental Illness Awareness Week – A time for reflection
PhRMA
OCTOBER 4, 2022
Each first week of October, Americans all across the country take time to reflect on an issue which is increasingly recognized as impacting everyone, whether it be directly as it does me, or indirectly through a family member or friend: mental illness. Mental Illness Awareness Week is an opportunity to raise awareness about the impacts of mental illness and to better understand and educate communities about what it means to face a mental illness, deal with significant moments of stress throughou
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Looking to the Southern Hemisphere for Clue’s on the 2022-2023 Flu Season
Drug Topics
OCTOBER 4, 2022
Does the severe flu season in the southern hemisphere hint at a tough season for the north?
To stay on the leading edge of oncology, AbbVie knows it has to take risks
PharmaVoice
OCTOBER 4, 2022
In a field that has seen rapid progress but ongoing areas of unmet need, AbbVie is betting on emerging tech.
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Be Proactive Ahead of Upcoming DIR Fee Changes
Drug Topics
OCTOBER 4, 2022
Changes to DIR fees are coming. Taking proactive steps can help pharmacies avoid feeling the pinch.
Teamwork, Technology Helps to Strengthen Pharmacy Services
Pharmacy Times
OCTOBER 4, 2022
Bri Morris, PharmD, senior director of Education and the Long-Term Care Division at the National Community Pharmacists Association, discusses the importance of teamwork in the pharmacy.
Signup to get articles personalized to your interests!
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
More Trending
Certain Kidney Function Measures May Determine Long-Term Physical Function Decline
Pharmacy Times
OCTOBER 4, 2022
Understanding long-term frailty trajectories with kidney function measures could help prevent worse adverse health outcomes in older patients.
OTC Hearing Aids Increase Accessibility for Patients with Mild to Moderate Hearing Loss
Drug Topics
OCTOBER 4, 2022
OTC hearing aids will be available nationwide on October 17, 2022.
Having a Marketing Representative on Staff Can Change How a Pharmacy Operates
Pharmacy Times
OCTOBER 4, 2022
With a trained representative focused on building relationships with prescribers in the community, pharmacies have the opportunity to significantly expand how they do business.
Opportunities for Improving Seasonal Vaccination Strategy
Drug Topics
OCTOBER 4, 2022
Final thoughts are provided as the panelists consider opportunities in the field of influenza vaccination.
Position Your Pharmacy for Expansion
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Continuing Education is Important for Pharmacists to Provide Best Care to Patients
Pharmacy Times
OCTOBER 4, 2022
Kurt Proctor, PhD, RPh, senior vice president of strategic initiatives at NCPA, discussed the importance of continue education for pharmacists.
Rethink Medication Adherence With Sustainable Multidose Packaging
Drug Topics
OCTOBER 4, 2022
Medication nonadherence carries a $500 billion price tag in the United States.
Participation push: How retail pharmacies can innovate clinical trials
Drug Store News
OCTOBER 4, 2022
CVS Health Clinical Trial Services was launched in 2021 with the goal of developing and executing a community-centric model for clinical trials.
Managing Flu Vaccine Shortages
Drug Topics
OCTOBER 4, 2022
Although there are no expected shortages of this season’s flu vaccines, knowing where to get help just in case is essential.
What the FDA's New Dosage Guidance Means for the Future of Clinical Research
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Boosting Immunization Efforts Can Fill in Coverage Gaps, Improve Pharmacies’ Financial Health
Pharmacy Times
OCTOBER 4, 2022
As pharmacy moves in the direction of patient-centered care, immunization plays a key role in this shift.
Opinion: How can the latest Alzheimer’s therapy reach patients? Follow this trustworthy process
STAT
OCTOBER 4, 2022
The press release issued by pharmaceutical companies Eisai and Biogen on Sept. 27 might someday be remembered as the beginning of a revolution in Alzheimer’s diagnosis and treatment. Years and years of failed Alzheimer’s trials created, and then fortified , doubts about whether drugs that attacked amyloid, a brain protein linked to Alzheimer’s disease, were a valid approach to its treatment.
It’s electric — speeding up the cell therapy process for scalability
PharmaVoice
OCTOBER 4, 2022
To improve the development of cell therapy-based treatments, many companies are turning to a technology that uses electric fields.
STAT+: At Verily, a growing line of business builds on a revolving door to the FDA
STAT
OCTOBER 4, 2022
After years spent building a seemingly slapdash set of medical initiatives, Verily seems to have a game plan. The Alphabet life sciences spinout is doubling down on the business of evidence generation , trying to build the tools and technical infrastructure that will help pharma and digital health customers run the next generation of clinical trials.
5 Reasons to Upgrade Your Pharmacy Management Software
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
The 2 areas in life sciences most in need of talent
PharmaVoice
OCTOBER 4, 2022
The industry is feeling the hiring crunch — here’s what pharma companies can do to mitigate the impact.
Take the 2022 Salary and Job Satisfaction Survey
Pharmacy Times
OCTOBER 4, 2022
Are you curious about what other pharmacists earn or how satisfied they are in their jobs?
Get a Ph.D. in health policy — from a single Powerpoint slide
STAT
OCTOBER 4, 2022
Looking for an actually concise explanation of a half-century’s worth of research and arguments about health care spending in the U.S.? You’re in luck: Government budget wonks, against all odds, condensed it down to a single PowerPoint slide. The slide is part of a broader report from the Congressional Budget Office that finds that capping the prices that hospitals, doctors, and other providers charge private health insurers would lower health care prices significantly more than ma
Study Links New Type 1 Diabetes Diagnoses, Prior COVID-19 in Pediatric Patients
Pharmacy Times
OCTOBER 4, 2022
Respiratory infections have been associated with onset of type 1 diabetes in previous research, but this risk was notably higher among those with COVID-19 in this study.
Solid Biosciences acquires AavantiBio, conducts $75 million private placement
pharmaphorum
OCTOBER 4, 2022
The life sciences company Solid Biosciences is merging with the privately-held gene therapy company AavantiBio in a deal which is expected to result in a combined sum of $215 million in cash and investments – projected to be enough for funding into 2025. AavantiBio, a precision genetic medicine company that was bankrolled by Solid’s rival Sarepta back in 2020, focuses on neuromuscular and cardiac rare diseases.
Experts Express Concern About Lower Rates of Flu, Pneumococcal Vaccination Rates
Pharmacy Times
OCTOBER 4, 2022
CDC Director Rochelle Walensky, MD, MPH, announced new preferential flu vaccine recommendations for individuals aged 65 years and older.
Building the Pharma Talent of Tomorrow from Today’s Workforce
PharmExec
OCTOBER 4, 2022
Hiring new employees may not be the answer to the war for talent.
Pharmacy Staff, Community Health Care Workers Can Team Up to Address Social Determinants of Health
Pharmacy Times
OCTOBER 4, 2022
Tripp Logan, PharmD, vice president at SEMO Rx Pharmacies and Logan & Seiler Inc discusses how pharmacy staff and community health care workers can work together to address social determinants of health.
Amazon reportedly pausing corporate retail employee hiring
Drug Store News
OCTOBER 4, 2022
According to a report, the company is set to close all job openings for corporate positions in its retail divisions.
STAT+: CAR-T therapy doesn’t work in all cancer cases. Scientists are starting to figure out why
STAT
OCTOBER 4, 2022
When CAR-T therapy works against blood cancer, it can work spectacularly, but cancer still returns for many patients. In lymphoma, scientists are just beginning to work out why over half of treated patients don’t experience lasting remission, depending on the product. Now two separate research teams have identified a possible culprit in the mix of engineered immune cells created as part of CAR-T therapy.
Pfizer acquires biopharma firm Biohaven for $11.6bn
Pharmaceutical Technology
OCTOBER 4, 2022
Pfizer has acquired commercial-stage biopharmaceutical firm Biohaven Pharmaceutical for $148.50 for each share or a total consideration of nearly $11.6bn in cash. In May, Pfizer entered a definitive agreement to acquire all outstanding shares of Biohaven which were not previously held by the former. . With the takeover, Biohaven became a wholly-owned Pfizer subsidiary.
Considerations for Mobile Health Technology Developers: Part 2
pharmaphorum
OCTOBER 4, 2022
In Part 1 of this series, general wellness devices and mobile medical applications (MMAs) were considered. Part 2 of this series is devoted to clinical decision support (CDS) software. On 27th September 2022, the Food and Drug Administration (FDA) issued its final guidance for industry and FDA staff clinical decision support (CDS) software, which has been anticipated since the Center for Devices and Radiological Health (CDRH) listed the guidance as a top priority for fiscal year 2022.
European Commission’s approval of Mounjaro provides hope within obesity space
Pharmaceutical Technology
OCTOBER 4, 2022
The type 2 diabetes (T2D) space recently witnessed a new approval: on 15 September, the European Commission (EC) authorised Eli Lilly’s Mounjaro (tirzepatide) for T2D patients. Mounjaro is a dual gastric inhibitory polypeptide (GIP)/glucagon-like peptide 1 (GLP-1) receptor agonist. This event is of paramount interest, and not only for T2D patients, as it could address vital unmet needs for other GIP/GLP-1 receptor agonist–treated diseases, including obesity.
Walmart kicks off Wellness Day for flu shots, updated COVID-19 boosters
Drug Store News
OCTOBER 4, 2022
Affordable immunizations and free wellness resources will be offered at 4,600-plus stores on Oct. 8.
Pilot to support ATMP research and development
European Pharmaceutical Review
OCTOBER 4, 2022
The European Medicines Agency (EMA) is set to launch a pilot aimed at helping advanced therapy medicinal product (ATMP) scientists navigate the regulatory challenges throughout the research process: from initial investigation to the development of medicines, to support non-profit’s solve unmet clinical needs and progress ground-breaking research for EU patients.
Let's personalize your content